A novel MAPK-microRNA signature is predictive of hormone-therapy resistance and poor outcome in ER-positive breast cancer

Philip C. Miller, Jennifer Clarke, Tulay Koru-Sengul, Joeli Brinkman, Dorraya El-Ashry

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A novel MAPK-microRNA signature is predictive of hormone-therapy resistance and poor outcome in ER-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences